Apolipoprotein E ϵ4 Count Affects Age at Onset of Alzheimer Disease,but Not Lifetime Susceptibility: The Cache County Study

Background The incidence of Alzheimer disease (AD) increases strongly with age, but little is known about the cumulative incidence of AD over a lifetime of 100 years, or its relationship to the polymorphic APOE locus that encodes apolipoprotein E. APOE is a strong genetic risk factor for AD Objectives To estimate the occurrence of AD as a function of age and number of APOE ϵ4 alleles; and to explore evidence for heterogeneity of AD risk related to APOE genotype and to other sources. Design Nonparametric and parametric survival analyses of AD incidence in prospective longitudinal study. Setting and Participants A total of 3308 elderly residents of Cache County, Utah. Main Outcome Measures Cumulative incidence of AD; in mixture models assuming susceptible and nonsusceptible individuals, the proportion of individuals not susceptible to AD at any age. Results Models that assumed a proportion of invulnerable individuals provided strongly improved fit to the data. These models estimated the 100-year lifetime incidence of AD at 72%, implying that 28% of individuals would not develop AD over any reasonable life expectancy. We confirmed the acceleration of AD onset in individuals with 1 or, especially, 2 APOE , ϵ4 alleles but observed no meaningful difference in 100-year lifetime incidence related to number of ϵ4 alleles. Conclusions The APOE ϵ4 allele acts as a potent risk factor for AD by accelerating onset. However, the risk of AD appears heterogeneous in ways independent of APOE.Some individuals seem destined to escape AD, even over an extended lifespan. Their relative invulnerability may reflect other genes or environmental factors that can be investigated.

[1]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[2]  M. Albert,et al.  Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. , 1989, JAMA.

[3]  Anthony F Jorm,et al.  The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): socio-demographic correlates, reliability, validity and some norms , 1989, Psychological Medicine.

[4]  R B D'Agostino,et al.  Computing estimates of incidence, including lifetime risk: Alzheimer's disease in the Framingham Study. The Practical Incidence Estimators (PIE) macro. , 2000, Statistics in medicine.

[5]  M. Norton,et al.  Dementia diagnoses from clinical and neuropsychological data compared , 2000, Neurology.

[6]  H. Chui,et al.  The Modified Mini-Mental State (3MS) examination. , 1987, The Journal of clinical psychiatry.

[7]  W. Weibull A Statistical Distribution Function of Wide Applicability , 1951 .

[8]  O. Hagnell,et al.  Incidence of dementia in the Lundby Study. , 1992, Neuroepidemiology.

[9]  J. Gallo,et al.  Performance characteristics of a two-stage dementia screen in a population sample. , 2000, Journal of clinical epidemiology.

[10]  K. Welsh-Bohmer,et al.  APOE-ε4 count predicts age when prevalence of AD increases, then declines , 1999, Neurology.

[11]  McGinnis Jm,et al.  Actual causes of death in the United States. , 1993 .

[12]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[13]  Chris Corcoran,et al.  Characteristics of a two-stage screen for incident dementia. , 2003, Journal of clinical epidemiology.

[14]  K. Manton,et al.  Rectangularization of the Survival Curve , 1991, Journal of aging and health.

[15]  M. Pericak-Vance,et al.  Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage. , 1991, American journal of human genetics.

[16]  L A Beckett,et al.  Age-specific incidence of Alzheimer's disease in a community population. , 1995, JAMA.

[17]  P. Zandi,et al.  Incidence of AD may decline in the early 90s for men, later for women , 2002, Neurology.

[18]  M. Folstein,et al.  Familial aggregation in Alzheimer dementia--I. A model for the age-dependent expression of an autosomal dominant gene. , 1986, Journal of psychiatric research.

[19]  M. Pericak-Vance,et al.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[20]  K. Welsh-Bohmer,et al.  APOE genotype predicts when — not whether — one is predisposed to develop Alzheimer disease , 1998, Nature Genetics.

[21]  Elisa T. Lee,et al.  Statistical Methods for Survival Data Analysis , 1994, IEEE Transactions on Reliability.

[22]  Jeremy M. Silverman,et al.  Reliability of the family history method in genetic studies of Alzheimer's disease and related dementias. , 1986, The American journal of psychiatry.